Abstract:Four-membered heterocycles such as oxetanes and azetidines represent attractive and emergent design options in medicinal chemistry due to their small and polar nature, and potential to significantly impact physiochemical properties of drug molecules. The challenging preparation of these derivatives, especially in a divergent manner, has severely limited the combination of oxetanes with other medicinally and biologically important groups. Consequently, there is a substantial demand for mild and effective synthetic strategies to access new oxetane and azetidine derivatives and molecular scaffolds. Herein, we report the development and use of oxetane sulfonyl fluorides (OSF) and azetidine sulfonyl fluorides (ASF), which behave as precursors to carbocations in an unusual defluorosulfonylation reaction pathway (deFS). The small-ring sulfonyl fluorides are activated under mild thermal conditions (60 ºC), and the generated reactive intermediates couple with a broad range of nucleophiles. This reactivity enables the generation of new chemical motifs that make attractive design elements for drug discovery. Notably, oxetane and azetidine-heterocyclic, -sulfoximine and -phosphonate derivatives are prepared, several of which do not have comparable carbonyl analogues. Alternatively, a SuFEx pathway under anionic conditions accesses oxetane-sulfur (VI) derivatives. We demonstrate the synthetic utility of novel OSF and ASF reagents through the synthesis of 11 drug analogues, showcasing their potential for subsequent diversification and facile inclusion into medicinal chemistry programs. Moreover, we propose the application of the OSF and ASF reagents as linker motifs and demonstrate the incorporation of pendant groups suitable for common conjugation reactions. Productive deFS reactions with E3 ligase recruiters such as pomalidomide and related derivatives provide new degrader motifs, and potential PROTAC linkers.

Discovery of Trypanosoma brucei inhibitors enabled by a unified synthesis of diverse sulfonyl fluorides

3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis

Appendage- and Scaffold-Diverse Electrophilic and Photoreactive Probes for Integrated Phenotypic Screening-Target Identification Campaigns via a Minimalist Bifunctional Isocyanide

Design and Synthesis of Α-Phenoxy-n-sulfonylphenyl Acetamides As Trypanosoma Brucei Leucyl-tRNA Synthetase Inhibitors.

Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis.

Design and <i>synthesis</i> of N-(3-sulfamoylphenyl)amides as <i>Trypanosoma brucei</i> leucyl-tRNA synthetase inhibitors

Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4H-tetrahydro-thiopyran-4-one S-Oxides: Their Interplay in a Cascade of Redox Reactions from Diarylideneacetones

Hit-to-lead optimization of novel benzimidazole phenylacetamides as broad spectrum trypanosomacides

Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery

Discovery of N-(4-sulfamoylphenyl)thioureas As Trypanosoma Brucei Leucyl-Trna Synthetase Inhibitors.

Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors

Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery

Streamlining SuFEx Inhibitor Development: A Unified Approach Using Orthogonal Sulfinate Protecting Groups

Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.

Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.

Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes

Optimization of benzenesulfonyl derivatives as anti- Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum

Identification of novel bromodomain inhibitors of Trypanosoma cruzi bromodomain factor 2 (TcBDF2) using a fluorescence polarization-based high-throughput assay

Chemical tools to expand the ligandable proteome: diversity-oriented synthesis-based photoreactive stereoprobes

Phenotypic‐based Discovery and Exploration of a Resorufin Scaffold with Activity against Mycobacterium Tuberculosis